Logo image of STZ

CONSTELLATION BRANDS INC-A (STZ) Stock Fundamental Analysis

USA - NYSE:STZ - US21036P1084 - Common Stock

134.05 USD
+1.01 (+0.76%)
Last: 9/18/2025, 2:51:10 PM
Fundamental Rating

4

Overall STZ gets a fundamental rating of 4 out of 10. We evaluated STZ against 32 industry peers in the Beverages industry. Both the profitability and the financial health of STZ get a neutral evaluation. Nothing too spectacular is happening here. STZ has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

STZ had positive earnings in the past year.
STZ had a positive operating cash flow in the past year.
In multiple years STZ reported negative net income over the last 5 years.
STZ had a positive operating cash flow in each of the past 5 years.
STZ Yearly Net Income VS EBIT VS OCF VS FCFSTZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

The Return On Assets of STZ (-1.99%) is worse than 71.88% of its industry peers.
STZ has a worse Return On Equity (-6.09%) than 81.25% of its industry peers.
STZ's Return On Invested Capital of 14.04% is amongst the best of the industry. STZ outperforms 81.25% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for STZ is in line with the industry average of 10.95%.
The 3 year average ROIC (12.24%) for STZ is below the current ROIC(14.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.99%
ROE -6.09%
ROIC 14.04%
ROA(3y)2.02%
ROA(5y)2.65%
ROE(3y)5.23%
ROE(5y)6.01%
ROIC(3y)12.24%
ROIC(5y)11.12%
STZ Yearly ROA, ROE, ROICSTZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

STZ has a better Operating Margin (33.29%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of STZ has grown nicely.
STZ has a better Gross Margin (51.67%) than 62.50% of its industry peers.
In the last couple of years the Gross Margin of STZ has remained more or less at the same level.
Industry RankSector Rank
OM 33.29%
PM (TTM) N/A
GM 51.67%
OM growth 3Y0.41%
OM growth 5Y2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.64%
GM growth 5Y0.98%
STZ Yearly Profit, Operating, Gross MarginsSTZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

4

2. Health

2.1 Basic Checks

STZ has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, STZ has less shares outstanding
Compared to 5 years ago, STZ has less shares outstanding
The debt/assets ratio for STZ is higher compared to a year ago.
STZ Yearly Shares OutstandingSTZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
STZ Yearly Total Debt VS Total AssetsSTZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

STZ has an Altman-Z score of 2.71. This is not the best score and indicates that STZ is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.71, STZ perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
STZ has a debt to FCF ratio of 5.60. This is a neutral value as STZ would need 5.60 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.60, STZ is doing good in the industry, outperforming 68.75% of the companies in the same industry.
STZ has a Debt/Equity ratio of 1.40. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of STZ (1.40) is worse than 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF 5.6
Altman-Z 2.71
ROIC/WACC2.09
WACC6.73%
STZ Yearly LT Debt VS Equity VS FCFSTZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

STZ has a Current Ratio of 1.07. This is a normal value and indicates that STZ is financially healthy and should not expect problems in meeting its short term obligations.
STZ has a Current ratio of 1.07. This is in the lower half of the industry: STZ underperforms 65.63% of its industry peers.
A Quick Ratio of 0.68 indicates that STZ may have some problems paying its short term obligations.
STZ has a Quick ratio (0.68) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.68
STZ Yearly Current Assets VS Current LiabilitesSTZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.50% over the past year.
The Earnings Per Share has been growing by 8.57% on average over the past years. This is quite good.
Looking at the last year, STZ shows a decrease in Revenue. The Revenue has decreased by -0.46% in the last year.
The Revenue has been growing slightly by 4.12% on average over the past years.
EPS 1Y (TTM)5.5%
EPS 3Y10.52%
EPS 5Y8.57%
EPS Q2Q%-9.8%
Revenue 1Y (TTM)-0.46%
Revenue growth 3Y4.99%
Revenue growth 5Y4.12%
Sales Q2Q%-5.52%

3.2 Future

STZ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.84% yearly.
STZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.43% yearly.
EPS Next Y-7.22%
EPS Next 2Y0.29%
EPS Next 3Y1.78%
EPS Next 5Y4.84%
Revenue Next Year-10.66%
Revenue Next 2Y-5.03%
Revenue Next 3Y-2.4%
Revenue Next 5Y1.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
STZ Yearly Revenue VS EstimatesSTZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
STZ Yearly EPS VS EstimatesSTZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.99, the valuation of STZ can be described as reasonable.
90.63% of the companies in the same industry are more expensive than STZ, based on the Price/Earnings ratio.
STZ is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.68, the valuation of STZ can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of STZ indicates a rather cheap valuation: STZ is cheaper than 93.75% of the companies listed in the same industry.
STZ's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 9.99
Fwd PE 9.68
STZ Price Earnings VS Forward Price EarningsSTZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

STZ's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. STZ is cheaper than 78.13% of the companies in the same industry.
84.38% of the companies in the same industry are more expensive than STZ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.43
EV/EBITDA 9.12
STZ Per share dataSTZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.17
EPS Next 2Y0.29%
EPS Next 3Y1.78%

5

5. Dividend

5.1 Amount

STZ has a Yearly Dividend Yield of 2.85%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.84, STZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, STZ has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.85%

5.2 History

The dividend of STZ is nicely growing with an annual growth rate of 6.29%!
STZ has been paying a dividend for at least 10 years, so it has a reliable track record.
STZ has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)6.29%
Div Incr Years9
Div Non Decr Years9
STZ Yearly Dividends per shareSTZ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

STZ has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of STZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-164.75%
EPS Next 2Y0.29%
EPS Next 3Y1.78%
STZ Yearly Income VS Free CF VS DividendSTZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

CONSTELLATION BRANDS INC-A

NYSE:STZ (9/18/2025, 2:51:10 PM)

134.05

+1.01 (+0.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)07-01 2025-07-01/amc
Earnings (Next)10-06 2025-10-06/bmo
Inst Owners78.34%
Inst Owner Change-0.2%
Ins Owners0.1%
Ins Owner Change0.1%
Market Cap23.63B
Analysts74
Price Target189.69 (41.51%)
Short Float %5.73%
Short Ratio3.71
Dividend
Industry RankSector Rank
Dividend Yield 2.85%
Yearly Dividend4.05
Dividend Growth(5Y)6.29%
DP-164.75%
Div Incr Years9
Div Non Decr Years9
Ex-Date07-30 2025-07-30 (1.02)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.37%
Min EPS beat(2)-3.57%
Max EPS beat(2)14.31%
EPS beat(4)2
Avg EPS beat(4)3.15%
Min EPS beat(4)-3.57%
Max EPS beat(4)14.31%
EPS beat(8)6
Avg EPS beat(8)4.55%
EPS beat(12)9
Avg EPS beat(12)4.55%
EPS beat(16)12
Avg EPS beat(16)4.24%
Revenue beat(2)1
Avg Revenue beat(2)-0.93%
Min Revenue beat(2)-2.48%
Max Revenue beat(2)0.61%
Revenue beat(4)1
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-3.72%
Max Revenue beat(4)0.61%
Revenue beat(8)2
Avg Revenue beat(8)-1.3%
Revenue beat(12)5
Avg Revenue beat(12)-0.49%
Revenue beat(16)9
Avg Revenue beat(16)0.5%
PT rev (1m)-11.28%
PT rev (3m)-13.72%
EPS NQ rev (1m)-14.89%
EPS NQ rev (3m)-16.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.7%
Revenue NQ rev (1m)-7.62%
Revenue NQ rev (3m)-8.6%
Revenue NY rev (1m)-3.41%
Revenue NY rev (3m)-4.44%
Valuation
Industry RankSector Rank
PE 9.99
Fwd PE 9.68
P/S 2.35
P/FCF 11.43
P/OCF 7.63
P/B 3.25
P/tB N/A
EV/EBITDA 9.12
EPS(TTM)13.42
EY10.01%
EPS(NY)13.85
Fwd EY10.33%
FCF(TTM)11.73
FCFY8.75%
OCF(TTM)17.58
OCFY13.11%
SpS57.08
BVpS41.21
TBVpS-2.41
PEG (NY)N/A
PEG (5Y)1.17
Profitability
Industry RankSector Rank
ROA -1.99%
ROE -6.09%
ROCE 18.04%
ROIC 14.04%
ROICexc 14.1%
ROICexgc 23.8%
OM 33.29%
PM (TTM) N/A
GM 51.67%
FCFM 20.55%
ROA(3y)2.02%
ROA(5y)2.65%
ROE(3y)5.23%
ROE(5y)6.01%
ROIC(3y)12.24%
ROIC(5y)11.12%
ROICexc(3y)12.3%
ROICexc(5y)11.2%
ROICexgc(3y)22.37%
ROICexgc(5y)20.22%
ROCE(3y)15.97%
ROCE(5y)14.37%
ROICexcg growth 3Y11.53%
ROICexcg growth 5Y13.24%
ROICexc growth 3Y14.12%
ROICexc growth 5Y13.2%
OM growth 3Y0.41%
OM growth 5Y2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.64%
GM growth 5Y0.98%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF 5.6
Debt/EBITDA 2.68
Cap/Depr 234.83%
Cap/Sales 10.25%
Interest Coverage 250
Cash Conversion 81.8%
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 0.68
Altman-Z 2.71
F-Score5
WACC6.73%
ROIC/WACC2.09
Cap/Depr(3y)275.65%
Cap/Depr(5y)283.18%
Cap/Sales(3y)11.86%
Cap/Sales(5y)11.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.5%
EPS 3Y10.52%
EPS 5Y8.57%
EPS Q2Q%-9.8%
EPS Next Y-7.22%
EPS Next 2Y0.29%
EPS Next 3Y1.78%
EPS Next 5Y4.84%
Revenue 1Y (TTM)-0.46%
Revenue growth 3Y4.99%
Revenue growth 5Y4.12%
Sales Q2Q%-5.52%
Revenue Next Year-10.66%
Revenue Next 2Y-5.03%
Revenue Next 3Y-2.4%
Revenue Next 5Y1.43%
EBIT growth 1Y-1.81%
EBIT growth 3Y5.43%
EBIT growth 5Y6.27%
EBIT Next Year3.78%
EBIT Next 3Y4.62%
EBIT Next 5Y5.17%
FCF growth 1Y33.52%
FCF growth 3Y4.91%
FCF growth 5Y1.21%
OCF growth 1Y16.32%
OCF growth 3Y5.23%
OCF growth 5Y4.32%